Company:  ALLARITY THERAPEUTICS, IN ... (ALLR)
Form Type:  10-K
Filing Date:  5/17/2022 
CIK:  0001860657 
Address:  210 BROADWAY
SUITE 201
 
City, State, Zip:  CAMBRIDGE, Massachusetts 02139 
Telephone:  401-426-4664 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.10  
Change: 
-0.05 (-4.35%)  
Trade Time: 
Sep 30  
Market Cap: 
$11.29M
Trade ALLR now with

© 2022  
Description of Business
We are a clinical stage biopharmaceutical company targeting some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates together with our proprietary DRP® companion diagnostics in a precision medicine approach. Our business strategy includes a focus on leveraging our proprietary DRP® companion diagnostics platform to streamline the drug development process and to identify patients that will benefit from therapeutic candidates that other biotechnology or pharmaceutical companies have abandoned or shelved after initiating clinical trials under an IND application filed with the FDA, including candidates that have failed to achieve statistical significance on the original endpoints established in their clinical trials.
Register and access this filing in:     
  FORM 10-K
    PART I
      ITEM 1. BUSINESS
      Legal Proceedings
      ITEM 1A. RISK FACTORS
      ITEM 1B. UNRESOLVED STAFF COMMENTS
      ITEM 2. PROPERTIES
      ITEM 4. MINE SAFETY DISCLOSURES
    PART II
      ITEM 5 - MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED ...
      ITEM 7. - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
        Results of Operations
        Liquidity, Capital Resources and Plan of Operations
      ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
      ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ...
      ITEM 9A. CONTROLS AND PROCEDURES
      ITEM 9B. OTHER INFORMATION
    PART III
      ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
        NAME AND TITLE
      ITEM 11. EXECUTIVE COMPENSATION
        COMPENSATION TABLE
        NAME AND TITLE
      ITEM 12 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS ...
        BENEFICIAL OWNERS
      ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND ...
      ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
    PART IV
      ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
    SIGNATURES
    REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
    Report of Independent Registered Public Accounting Firm
    BALANCE SHEET
    INCOME STATEMENT
    STOCKHOLDERS EQUITY
    STOCKHOLDERS EQUITY
    CASH FLOW
    CASH FLOW
    NOTES TO FINANCIAL STATEMENTS
      BALANCE SHEET
  EXHIBIT 4.VI
  EXHIBIT 10.17
  EXHIBIT 10.18
  EXHIBIT 10.19
  EXHIBIT 10.20
  EXHIBIT 10.21
  EXHIBIT 21.1
    SUBSIDIARIES
  EXHIBIT 31.1
    CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER
  EXHIBIT 31.2
    CERTIFICATIONS OF CHIEF FINANCIAL OFFICER
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO
  EXHIBIT 32.2
    CERTIFICATION PURSUANT TO